Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity

Carbohydrate Polymers

Volumn 97, Issue 2, 2013, Pages 684-689

  Achour, Oussama ^a   Bridiau, Nicolas ^a   Godhbani, Azza ^a   Le Joubioux, Florian ^a   Juchereau, Stephanie Bordenave ^a   Sannier, Fredéric ^a   Piot, Jean Marie ^a   Arnaudin, Ingrid Fruitier ^a   Maugard, Thierry ^a  

^a UNIVERSITÉ DE LA ROCHELLE   (France)

Author keywords

Anti IIa; Anti Xa; Depolymerization; Heparin; Ultrasonic waves

Indexed keywords

DEPOLYMERIZATION; DRUG PRODUCTS; MOLECULAR WEIGHT; ULTRASONIC WAVES;

ANTI-IIA; ANTI-XA; ANTICOAGULANT ACTIVITIES; ANTICOAGULANT PROPERTIES; AVERAGE MOLECULAR WEIGHT; ENZYMATIC DEPOLYMERIZATION; HEPARIN; LOW-MOLECULAR WEIGHT HEPARINS;

POLYSACCHARIDES;

EID: 84879053744     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.05.046     Document Type: Article

References (26)

1. Bisio, A., Guglieri, S., Frigerio, M., Torri, G., Vismara, E., Cornelli, U., et al. (2004). Controlled ray irradiation of heparin generates oligosaccharides enriched in highly sulfated sequences. Carbohydrate Polymers, 55, 101-112.
2. Cosmi, B., & Palareti, G. (2012). Old and new heparins. Thrombosis Research, 129, 388-391.
3. Czechowska-Biskup, R., Rokita, B., Lotfy, S., Ulanski, P., & Rosiak, J. M. (2005). Degradation of chitosan and starch by 360-kHz ultrasound. Carbohydrate Polymers, 60, 175-184. (Pubitemid 40480073)
4. Da Silva, M. S., & Sobel, M. (2002). Anticoagulants: To bleed or not to bleed, that is the question. Seminars in Vascular Surgery, 15, 256-267.
5. Emanuele, R. M., & Fareed, J. (1987). The effect of molecular weight on the bioavailability of heparin. Thrombosis Research, 48, 591-596.
6. Gao, G., Jiao, Q., Ding, Y., & Chen, L. (2003). Study on quantitative assay of chondroitin sulfate with a spectrophotometric method of azure A. Guang Pu Xue Yu Guang Pu Fen Xi, 23, 600-602.
7. Grönroos, A., Pirkonen, P., Heikkinen, J., Ihalainen, J., Mursunen, H., & Sekki, H. (2001). Ultrasonic depolymerization of aqueous polyvinyl alcohol. Ultrasonics Sonochemistry, 8, 259-264.
8. Hao, L., Zhang, Q., Yu, T., Cheng, Y., & Ji, S. (2011). Antagonistic effects of ultralow- molecular-weight heparin on A25-35-induced apoptosis in cultured rat cortical neurons. Brain Research, 1368, 1-10.
9. Jaques, L. B., Ballieux, R. E., Dietrich, C. P., & Kavanagh, L. W. (1968). A microelectrophoresis method for heparin. Canadian Journal of Physiology and Pharmacology, 46, 351-360.
10. Javot, L., Lecompte, T., Rabiskova, M., & Maincent, P. (2009). Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio. Journal of Controlled Release, 139, 8-14.
11. Kawasaki, H., Takeda, Y., & Arakawa, R. (2007). Mass spectrometric analysis for high molecular weight synthetic polymers using ultrasonic degradation and the mechanism of degradation. Analytical Chemistry, 79, 4182-4187. (Pubitemid 46903170)
12. Korir, A. K., & Larive, C. K. (2008). Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate. Analytical and Bioanalytical Chemistry, 393, 155-169. (Pubitemid 50295243)
13. Lii, C., Chen, C.-H., Yeh, A.-I., & Lai, V. M.-F. (1999). Preliminary study on the degradation kinetics of agarose and carrageenans by ultrasound. Food Hydrocolloids, 13, 477-481. (Pubitemid 129499919)
14. Linhardt, R. J., & Gunay, N. S. (1999). Production and chemical processing of low molecular weight heparins. Seminars in Thrombosis and Hemostasis, 25, 5-16. (Pubitemid 29517028)
15. Lorimer, J. P., Mason, T. J., Cuthbert, T. C., & Brookfield, E. A. (1995). Effect of ultrasound on the degradation of aqueous native dextran. Ultrasonics Sonochemistry, 2, S55-S57.
16. Milas, M., Rinaudo, M., & Tinland, B. (1986). Comparative depolymerization of xanthan gum by ultrasonic and enzymic treatments. Rheological and structural properties. Carbohydrate Polymers, 6, 95-107.
17. Miyazaki, T., Yomota, C., & Okada, S. (2001). Ultrasonic depolymerization of hyaluronic acid. Polymer Degradation and Stability, 74, 77-85. (Pubitemid 32867076)
18. Mousa, S. A. (2002). The low molecular weight heparin, tinzaparin, in thrombosis and beyond. Cardiovascular Drug Reviews, 20, 199-216. (Pubitemid 35204768)
19. Mulloy, B., Hogwood, J., & Gray, E. (2010). Assays and reference materials for current and future applications of heparins. Biologicals, 38, 459-466.
20. Naggi, A., & Torri, G. (1988). Depolymerized and supersulfated heparin, process for its preparation and pharmaceutical compositions. U.S. Patent 4,791,195 February 23.
21. Petit, A.-C., Noiret, N., Guezennec, J., Gondrexon, N., & Colliec-Jouault, S. (2007). Ultrasonic depolymerization of an exopolysaccharide produced by a bacterium isolated from a deep-sea hydrothermal vent polychaete annelid. Ultrasonics Sonochemistry, 14, 107-112. (Pubitemid 44499064)
22. Sasisekharan, R., & Venkataraman, G. (2000). Heparin and heparan sulfate: Biosynthesis, structure and function. Current Opinion in Chemical Biology, 4, 626-631.
23. Sommers, C. D., Ye, H., Kolinski, R. E., Nasr, M., Buhse, L. F., Al-Hakim, A., et al. (2011). Characterization of currently marketed heparin products: Analysis of molecular weight and heparinase-I digest patterns. Analytical and Bioanalytical Chemistry, 401, 2445-2454.
24. U.S. FDA. (2002). Determination that ardeparin sodium injection was not withdrawn from sale for reasons of safety or effectiveness. Notice No. 01 P-04471.
25. Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., et al. (1995). Heparin-induced thrombocytopenia in patients treated with lowmolecular- weight heparin or unfractionated heparin. The New England Journal of Medicine, 332, 1330-1335.
26. Ye, F., Kuang, Y., Chen, S., Zhang, C., Chen, Y., & Xing, X.-H. (2009). Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor using maltose binding protein fused heparinase I. Biochemical Engineering Journal, 46, 193-198.